|
Market Closed -
Nasdaq
22:59:48 26/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.7540 USD | +1.11% |
|
-2.08% | -33.86% |
| 02:33pm | Top Premarket Gainers | MT |
| 10-12 | Iridex Says Glaucoma Therapy Lowers Eye Pressure, Reduces Medication Use | MT |
Evolution of the Average Target: IRIDEX Corporation
Evolution of the Target Price: IRIDEX Corporation
Changes in Analyst Recommendations: IRIDEX Corporation
6.AF_mGuvhcn7PrKOFH-mkUyxfqusZxyi3eM0h9YKRmEQ.LQ-VUKiuCg32nvPzLaXQEBws4MZ1sWvRL69Fp-rdwiZ5LdZ4hLcnC_fKmw~593d90f79920a315ea3eeecb8d8ce76f
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | - | - | +268.78% | |||
| +11.44% | |||||
| +12.45% | |||||
| +5.75% | |||||
| +26.55% | |||||
| -6.96% | |||||
| +8.44% | |||||
| +13.83% | |||||
| +4.95% | |||||
| +2.69% | |||||
| Average | +34.79% | |||||
| Weighted average by Cap. | +9.82% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.7457USD
Average target price
2.750USD
Spread / Average Target
+268.78%
High Price Target
2.750USD
Spread / Highest target
+268.78%
Low Price Target
2.750USD
Spread / Lowest Target
+268.78%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- IRIX Stock
- Consensus IRIDEX Corporation
Select your edition
All financial news and data tailored to specific country editions
